This excerpt taken from the GENZ 8-K filed Jan 4, 2008.
This press release contains forward-looking statements, including without limitation statements about: expectations and plans related to the commercialization and manufacture of Aldurazyme; estimates concerning the MPS I patient population, and the anticipated benefits of the restructuring. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties include, among others: the effectiveness of Genzymes commercialization plan for Aldurazyme and Genzymes sales
force; BioMarins ability to manufacture sufficient quantities of product and to do so in a timely and cost efficient manner; the accuracy of the companies information concerning the MPS I patient population; the content and actual timing of decisions by regulatory authorities concerning marketing applications, labeling and pricing for Aldurazyme and manufacturing facilities to be used for Aldurazyme; the companies ability to obtain and maintain adequate patent and other proprietary rights protection for Aldurazyme; and those factors detailed in BioMarins and Genzymes filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption Risk Factors in BioMarins 2006 Annual Report on Form 10-K, as amended, the factors contained in BioMarins reports on Form 8-K, and the factors discussed under the caption Risk Factors in Genzymes Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Neither BioMarin nor Genzyme is under any obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.
BioMarin® is a registered trademark of BioMarin Pharmaceutical Inc.
Genzyme® is a registered trademark of Genzyme Corporation.
Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC.
All rights reserved.